These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27037844)

  • 1. Rationale and design for an investigation to optimize selective serotonin reuptake inhibitor treatment for pregnant women with depression.
    Avram MJ; Stika CS; Rasmussen-Torvik LJ; Ciolino JD; Pinheiro E; George AL; Wisner KL
    Clin Pharmacol Ther; 2016 Jul; 100(1):31-3. PubMed ID: 27037844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of antidepressants during pregnancy].
    Svensson M; Reimers A; Reis M
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32315439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
    Ornoy A; Koren G
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antidepressants in pregnancy: focus on maternal risks.
    Gadot Y; Koren G
    J Obstet Gynaecol Can; 2015 Jan; 37(1):56-63. PubMed ID: 25764038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitor antidepressants in pregnancy].
    Ramió X; Aguilera C
    Med Clin (Barc); 2007 Jun; 129(5):194-6. PubMed ID: 17669337
    [No Abstract]   [Full Text] [Related]  

  • 8. SSRI use during pregnancy.
    Tran H; Robb AS
    Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns.
    Dubnov-Raz G; Juurlink DN; Fogelman R; Merlob P; Ito S; Koren G; Finkelstein Y
    Pediatrics; 2008 Sep; 122(3):e710-5. PubMed ID: 18762507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
    Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
    [No Abstract]   [Full Text] [Related]  

  • 11. Unplanned pregnancy and discontinuation of SSRIs in pregnant women with previously treated affective disorder.
    Roca A; Imaz ML; Torres A; Plaza A; Subirà S; Valdés M; Martin-Santos R; Garcia-Esteve L
    J Affect Disord; 2013 Sep; 150(3):807-13. PubMed ID: 23566335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.
    ACOG Committee on Obstetric Practice
    Obstet Gynecol; 2006 Dec; 108(6):1601-3. PubMed ID: 17138801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship of recent antidepressants in the short-term treatment of depression.
    Berney P
    Dialogues Clin Neurosci; 2005; 7(3):249-62. PubMed ID: 16156383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitors as First-Line Antidepressant Therapy for Perinatal Depression.
    Latendresse G; Elmore C; Deneris A
    J Midwifery Womens Health; 2017 May; 62(3):317-328. PubMed ID: 28485526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of selective serotonin reuptake inhibitors in pregnancy.
    Wen SW; Walker M
    J Obstet Gynaecol Can; 2004 Sep; 26(9):819-22. PubMed ID: 15361279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands.
    Molenaar NM; Lambregtse-van den Berg MP; Bonsel GJ
    Arch Womens Ment Health; 2020 Feb; 23(1):71-79. PubMed ID: 30762147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.
    Hostetter A; Stowe ZN; Strader JR; McLaughlin E; Llewellyn A
    Depress Anxiety; 2000; 11(2):51-7. PubMed ID: 10812529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of antidepressant use in pregnant and nursing women.
    Lamberg L
    JAMA; 1999 Jul; 282(3):222-3. PubMed ID: 10422977
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F
    Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.